Glaucoma, a group of diseases that damage the eye's optic nerve, can lead to progressive, irreversible vision loss. However, early detection and proper management may help prevent the potentially serious outcomes of glaucoma.
In the U.S., more than 2 million individuals are estimated to be living with open-angle glaucoma, and that number is expected to increase by 50 percent — to more than 3 million — by 2020. However, glaucoma continues to be under-diagnosed and associated with poor treatment adherence.
Americans ages 40 and older need to be better educated about the risk factors of glaucoma, the silent nature of the condition and its potentially serious outcomes, according to the Glaucoma Working Group, a panel of experts including The Glaucoma Foundation, the Alliance for Aging Research, and leading ophthalmologists, in partnership with and funded by Merck.
The Glaucoma Working Group encourages aging Americans to visit its new TAKE on Glaucoma (Take Action to Know your Eyes) website to learn about the risks, the importance of a comprehensive eye exam (including dilation) and proper disease management, if diagnosed.